Global Mesalamine (Lialda) Market Growth (Status and Outlook) 2025-2031

September 2025 | 109 pages | ID: G528ED349028EN
LP Information

Abstracts

According to this study, the global Mesalamine (Lialda) market size will reach US$ 249 million by 2031.

An anti-inflammatory agent, structurally related to the salicylates and non-steroidal anti-inflammatory drugs like acetylsalicylic acid, which is active in inflammatory bowel disease 2. It is considered to be the active moiety of sulphasalazine. (From Martindale, The Extra Pharmacopoeia, 30th ed) Although demonstrably effective in treating and maintaining remission for ulcerative colitis, mesalazine has historically faced a number of issues regarding its lack of stability as a pharmaceutical agent.

United States market for Mesalamine (Lialda) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Mesalamine (Lialda) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Mesalamine (Lialda) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Mesalamine (Lialda) players cover Dr.Falk Pharma, Ferring, Ethypharm Pharmaceutical, Shanghai Pharmaceutical, Tillotts Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Mesalamine (Lialda) Industry Forecast” looks at past sales and reviews total world Mesalamine (Lialda) sales in 2024, providing a comprehensive analysis by region and market sector of projected Mesalamine (Lialda) sales for 2025 through 2031. With Mesalamine (Lialda) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalamine (Lialda) industry.

This Insight Report provides a comprehensive analysis of the global Mesalamine (Lialda) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mesalamine (Lialda) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mesalamine (Lialda) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalamine (Lialda) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalamine (Lialda).

This report presents a comprehensive overview, market shares, and growth opportunities of Mesalamine (Lialda) market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Enemas
• Tablets
• Suppositories
• Other

Segmentation by Application:

• Colitis
• Crohn's Disease
• Proctitis
• Diarrheal Irritable Bowel Syndrome
• Diverticulitis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Dr.Falk Pharma
• Ferring
• Ethypharm Pharmaceutical
• Shanghai Pharmaceutical
• Tillotts Pharma
• Holy Stone Healthcare
• Giuliani
• Zeria
• Lupin
• Heilongjiang Tianhong Pharmaceutical
• HENGCHENG PHARMACEUTICAL
• KWAI FA Pharmaceutical Group

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mesalamine (Lialda) Market Size (2020-2031)
  2.1.2 Mesalamine (Lialda) Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Mesalamine (Lialda) by Country/Region (2020, 2024 & 2031)
2.2 Mesalamine (Lialda) Segment by Type
  2.2.1 Enemas
  2.2.2 Tablets
  2.2.3 Suppositories
  2.2.4 Other
2.3 Mesalamine (Lialda) Market Size by Type
  2.3.1 Mesalamine (Lialda) Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Mesalamine (Lialda) Market Size Market Share by Type (2020-2025)
2.4 Mesalamine (Lialda) Segment by Application
  2.4.1 Colitis
  2.4.2 Crohn's Disease
  2.4.3 Proctitis
  2.4.4 Diarrheal Irritable Bowel Syndrome
  2.4.5 Diverticulitis
  2.4.6 Other
2.5 Mesalamine (Lialda) Market Size by Application
  2.5.1 Mesalamine (Lialda) Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Mesalamine (Lialda) Market Size Market Share by Application (2020-2025)

3 MESALAMINE (LIALDA) MARKET SIZE BY PLAYER

3.1 Mesalamine (Lialda) Market Size Market Share by Player
  3.1.1 Global Mesalamine (Lialda) Revenue by Player (2020-2025)
  3.1.2 Global Mesalamine (Lialda) Revenue Market Share by Player (2020-2025)
3.2 Global Mesalamine (Lialda) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MESALAMINE (LIALDA) BY REGION

4.1 Mesalamine (Lialda) Market Size by Region (2020-2025)
4.2 Global Mesalamine (Lialda) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mesalamine (Lialda) Market Size Growth (2020-2025)
4.4 APAC Mesalamine (Lialda) Market Size Growth (2020-2025)
4.5 Europe Mesalamine (Lialda) Market Size Growth (2020-2025)
4.6 Middle East & Africa Mesalamine (Lialda) Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Mesalamine (Lialda) Market Size by Country (2020-2025)
5.2 Americas Mesalamine (Lialda) Market Size by Type (2020-2025)
5.3 Americas Mesalamine (Lialda) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mesalamine (Lialda) Market Size by Region (2020-2025)
6.2 APAC Mesalamine (Lialda) Market Size by Type (2020-2025)
6.3 APAC Mesalamine (Lialda) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Mesalamine (Lialda) Market Size by Country (2020-2025)
7.2 Europe Mesalamine (Lialda) Market Size by Type (2020-2025)
7.3 Europe Mesalamine (Lialda) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mesalamine (Lialda) by Region (2020-2025)
8.2 Middle East & Africa Mesalamine (Lialda) Market Size by Type (2020-2025)
8.3 Middle East & Africa Mesalamine (Lialda) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MESALAMINE (LIALDA) MARKET FORECAST

10.1 Global Mesalamine (Lialda) Forecast by Region (2026-2031)
  10.1.1 Global Mesalamine (Lialda) Forecast by Region (2026-2031)
  10.1.2 Americas Mesalamine (Lialda) Forecast
  10.1.3 APAC Mesalamine (Lialda) Forecast
  10.1.4 Europe Mesalamine (Lialda) Forecast
  10.1.5 Middle East & Africa Mesalamine (Lialda) Forecast
10.2 Americas Mesalamine (Lialda) Forecast by Country (2026-2031)
  10.2.1 United States Market Mesalamine (Lialda) Forecast
  10.2.2 Canada Market Mesalamine (Lialda) Forecast
  10.2.3 Mexico Market Mesalamine (Lialda) Forecast
  10.2.4 Brazil Market Mesalamine (Lialda) Forecast
10.3 APAC Mesalamine (Lialda) Forecast by Region (2026-2031)
  10.3.1 China Mesalamine (Lialda) Market Forecast
  10.3.2 Japan Market Mesalamine (Lialda) Forecast
  10.3.3 Korea Market Mesalamine (Lialda) Forecast
  10.3.4 Southeast Asia Market Mesalamine (Lialda) Forecast
  10.3.5 India Market Mesalamine (Lialda) Forecast
  10.3.6 Australia Market Mesalamine (Lialda) Forecast
10.4 Europe Mesalamine (Lialda) Forecast by Country (2026-2031)
  10.4.1 Germany Market Mesalamine (Lialda) Forecast
  10.4.2 France Market Mesalamine (Lialda) Forecast
  10.4.3 UK Market Mesalamine (Lialda) Forecast
  10.4.4 Italy Market Mesalamine (Lialda) Forecast
  10.4.5 Russia Market Mesalamine (Lialda) Forecast
10.5 Middle East & Africa Mesalamine (Lialda) Forecast by Region (2026-2031)
  10.5.1 Egypt Market Mesalamine (Lialda) Forecast
  10.5.2 South Africa Market Mesalamine (Lialda) Forecast
  10.5.3 Israel Market Mesalamine (Lialda) Forecast
  10.5.4 Turkey Market Mesalamine (Lialda) Forecast
10.6 Global Mesalamine (Lialda) Forecast by Type (2026-2031)
10.7 Global Mesalamine (Lialda) Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Mesalamine (Lialda) Forecast

11 KEY PLAYERS ANALYSIS

11.1 Dr.Falk Pharma
  11.1.1 Dr.Falk Pharma Company Information
  11.1.2 Dr.Falk Pharma Mesalamine (Lialda) Product Offered
  11.1.3 Dr.Falk Pharma Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Dr.Falk Pharma Main Business Overview
  11.1.5 Dr.Falk Pharma Latest Developments
11.2 Ferring
  11.2.1 Ferring Company Information
  11.2.2 Ferring Mesalamine (Lialda) Product Offered
  11.2.3 Ferring Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Ferring Main Business Overview
  11.2.5 Ferring Latest Developments
11.3 Ethypharm Pharmaceutical
  11.3.1 Ethypharm Pharmaceutical Company Information
  11.3.2 Ethypharm Pharmaceutical Mesalamine (Lialda) Product Offered
  11.3.3 Ethypharm Pharmaceutical Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Ethypharm Pharmaceutical Main Business Overview
  11.3.5 Ethypharm Pharmaceutical Latest Developments
11.4 Shanghai Pharmaceutical
  11.4.1 Shanghai Pharmaceutical Company Information
  11.4.2 Shanghai Pharmaceutical Mesalamine (Lialda) Product Offered
  11.4.3 Shanghai Pharmaceutical Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Shanghai Pharmaceutical Main Business Overview
  11.4.5 Shanghai Pharmaceutical Latest Developments
11.5 Tillotts Pharma
  11.5.1 Tillotts Pharma Company Information
  11.5.2 Tillotts Pharma Mesalamine (Lialda) Product Offered
  11.5.3 Tillotts Pharma Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Tillotts Pharma Main Business Overview
  11.5.5 Tillotts Pharma Latest Developments
11.6 Holy Stone Healthcare
  11.6.1 Holy Stone Healthcare Company Information
  11.6.2 Holy Stone Healthcare Mesalamine (Lialda) Product Offered
  11.6.3 Holy Stone Healthcare Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Holy Stone Healthcare Main Business Overview
  11.6.5 Holy Stone Healthcare Latest Developments
11.7 Giuliani
  11.7.1 Giuliani Company Information
  11.7.2 Giuliani Mesalamine (Lialda) Product Offered
  11.7.3 Giuliani Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Giuliani Main Business Overview
  11.7.5 Giuliani Latest Developments
11.8 Zeria
  11.8.1 Zeria Company Information
  11.8.2 Zeria Mesalamine (Lialda) Product Offered
  11.8.3 Zeria Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Zeria Main Business Overview
  11.8.5 Zeria Latest Developments
11.9 Lupin
  11.9.1 Lupin Company Information
  11.9.2 Lupin Mesalamine (Lialda) Product Offered
  11.9.3 Lupin Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Lupin Main Business Overview
  11.9.5 Lupin Latest Developments
11.10 Heilongjiang Tianhong Pharmaceutical
  11.10.1 Heilongjiang Tianhong Pharmaceutical Company Information
  11.10.2 Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Product Offered
  11.10.3 Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Heilongjiang Tianhong Pharmaceutical Main Business Overview
  11.10.5 Heilongjiang Tianhong Pharmaceutical Latest Developments
11.11 HENGCHENG PHARMACEUTICAL
  11.11.1 HENGCHENG PHARMACEUTICAL Company Information
  11.11.2 HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Product Offered
  11.11.3 HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 HENGCHENG PHARMACEUTICAL Main Business Overview
  11.11.5 HENGCHENG PHARMACEUTICAL Latest Developments
11.12 KWAI FA Pharmaceutical Group
  11.12.1 KWAI FA Pharmaceutical Group Company Information
  11.12.2 KWAI FA Pharmaceutical Group Mesalamine (Lialda) Product Offered
  11.12.3 KWAI FA Pharmaceutical Group Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 KWAI FA Pharmaceutical Group Main Business Overview
  11.12.5 KWAI FA Pharmaceutical Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Mesalamine (Lialda) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Mesalamine (Lialda) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Enemas
Table 4. Major Players ofTablets
Table 5. Major Players of Suppositories
Table 6. Major Players of Other
Table 7. Mesalamine (Lialda) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Mesalamine (Lialda) Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Mesalamine (Lialda) Market Size Market Share by Type (2020-2025)
Table 10. Mesalamine (Lialda) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Mesalamine (Lialda) Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Mesalamine (Lialda) Market Size Market Share by Application (2020-2025)
Table 13. Global Mesalamine (Lialda) Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Mesalamine (Lialda) Revenue Market Share by Player (2020-2025)
Table 15. Mesalamine (Lialda) Key Players Head office and Products Offered
Table 16. Mesalamine (Lialda) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Mesalamine (Lialda) Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Mesalamine (Lialda) Market Size Market Share by Region (2020-2025)
Table 21. Global Mesalamine (Lialda) Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Mesalamine (Lialda) Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Mesalamine (Lialda) Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Mesalamine (Lialda) Market Size Market Share by Country (2020-2025)
Table 25. Americas Mesalamine (Lialda) Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Mesalamine (Lialda) Market Size Market Share by Type (2020-2025)
Table 27. Americas Mesalamine (Lialda) Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Mesalamine (Lialda) Market Size Market Share by Application (2020-2025)
Table 29. APAC Mesalamine (Lialda) Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Mesalamine (Lialda) Market Size Market Share by Region (2020-2025)
Table 31. APAC Mesalamine (Lialda) Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Mesalamine (Lialda) Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Mesalamine (Lialda) Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Mesalamine (Lialda) Market Size Market Share by Country (2020-2025)
Table 35. Europe Mesalamine (Lialda) Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Mesalamine (Lialda) Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Mesalamine (Lialda) Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Mesalamine (Lialda) Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Mesalamine (Lialda) Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Mesalamine (Lialda)
Table 41. Key Market Challenges & Risks of Mesalamine (Lialda)
Table 42. Key Industry Trends of Mesalamine (Lialda)
Table 43. Global Mesalamine (Lialda) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Mesalamine (Lialda) Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Mesalamine (Lialda) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Mesalamine (Lialda) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Dr.Falk Pharma Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 48. Dr.Falk Pharma Mesalamine (Lialda) Product Offered
Table 49. Dr.Falk Pharma Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Dr.Falk Pharma Main Business
Table 51. Dr.Falk Pharma Latest Developments
Table 52. Ferring Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 53. Ferring Mesalamine (Lialda) Product Offered
Table 54. Ferring Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Ferring Main Business
Table 56. Ferring Latest Developments
Table 57. Ethypharm Pharmaceutical Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 58. Ethypharm Pharmaceutical Mesalamine (Lialda) Product Offered
Table 59. Ethypharm Pharmaceutical Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Ethypharm Pharmaceutical Main Business
Table 61. Ethypharm Pharmaceutical Latest Developments
Table 62. Shanghai Pharmaceutical Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 63. Shanghai Pharmaceutical Mesalamine (Lialda) Product Offered
Table 64. Shanghai Pharmaceutical Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Shanghai Pharmaceutical Main Business
Table 66. Shanghai Pharmaceutical Latest Developments
Table 67. Tillotts Pharma Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 68. Tillotts Pharma Mesalamine (Lialda) Product Offered
Table 69. Tillotts Pharma Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Tillotts Pharma Main Business
Table 71. Tillotts Pharma Latest Developments
Table 72. Holy Stone Healthcare Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 73. Holy Stone Healthcare Mesalamine (Lialda) Product Offered
Table 74. Holy Stone Healthcare Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Holy Stone Healthcare Main Business
Table 76. Holy Stone Healthcare Latest Developments
Table 77. Giuliani Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 78. Giuliani Mesalamine (Lialda) Product Offered
Table 79. Giuliani Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Giuliani Main Business
Table 81. Giuliani Latest Developments
Table 82. Zeria Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 83. Zeria Mesalamine (Lialda) Product Offered
Table 84. Zeria Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Zeria Main Business
Table 86. Zeria Latest Developments
Table 87. Lupin Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 88. Lupin Mesalamine (Lialda) Product Offered
Table 89. Lupin Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Lupin Main Business
Table 91. Lupin Latest Developments
Table 92. Heilongjiang Tianhong Pharmaceutical Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 93. Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Product Offered
Table 94. Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Heilongjiang Tianhong Pharmaceutical Main Business
Table 96. Heilongjiang Tianhong Pharmaceutical Latest Developments
Table 97. HENGCHENG PHARMACEUTICAL Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 98. HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Product Offered
Table 99. HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. HENGCHENG PHARMACEUTICAL Main Business
Table 101. HENGCHENG PHARMACEUTICAL Latest Developments
Table 102. KWAI FA Pharmaceutical Group Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 103. KWAI FA Pharmaceutical Group Mesalamine (Lialda) Product Offered
Table 104. KWAI FA Pharmaceutical Group Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. KWAI FA Pharmaceutical Group Main Business
Table 106. KWAI FA Pharmaceutical Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Mesalamine (Lialda) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mesalamine (Lialda) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Mesalamine (Lialda) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Mesalamine (Lialda) Sales Market Share by Country/Region (2024)
Figure 8. Mesalamine (Lialda) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Mesalamine (Lialda) Market Size Market Share by Type in 2024
Figure 10. Mesalamine (Lialda) in Colitis
Figure 11. Global Mesalamine (Lialda) Market: Colitis (2020-2025) & ($ millions)
Figure 12. Mesalamine (Lialda) in Crohn's Disease
Figure 13. Global Mesalamine (Lialda) Market: Crohn's Disease (2020-2025) & ($ millions)
Figure 14. Mesalamine (Lialda) in Proctitis
Figure 15. Global Mesalamine (Lialda) Market: Proctitis (2020-2025) & ($ millions)
Figure 16. Mesalamine (Lialda) in Diarrheal Irritable Bowel Syndrome
Figure 17. Global Mesalamine (Lialda) Market: Diarrheal Irritable Bowel Syndrome (2020-2025) & ($ millions)
Figure 18. Mesalamine (Lialda) in Diverticulitis
Figure 19. Global Mesalamine (Lialda) Market: Diverticulitis (2020-2025) & ($ millions)
Figure 20. Mesalamine (Lialda) in Other
Figure 21. Global Mesalamine (Lialda) Market: Other (2020-2025) & ($ millions)
Figure 22. Global Mesalamine (Lialda) Market Size Market Share by Application in 2024
Figure 23. Global Mesalamine (Lialda) Revenue Market Share by Player in 2024
Figure 24. Global Mesalamine (Lialda) Market Size Market Share by Region (2020-2025)
Figure 25. Americas Mesalamine (Lialda) Market Size 2020-2025 ($ millions)
Figure 26. APAC Mesalamine (Lialda) Market Size 2020-2025 ($ millions)
Figure 27. Europe Mesalamine (Lialda) Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Mesalamine (Lialda) Market Size 2020-2025 ($ millions)
Figure 29. Americas Mesalamine (Lialda) Value Market Share by Country in 2024
Figure 30. United States Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Mesalamine (Lialda) Market Size Market Share by Region in 2024
Figure 35. APAC Mesalamine (Lialda) Market Size Market Share by Type (2020-2025)
Figure 36. APAC Mesalamine (Lialda) Market Size Market Share by Application (2020-2025)
Figure 37. China Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 41. India Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Mesalamine (Lialda) Market Size Market Share by Country in 2024
Figure 44. Europe Mesalamine (Lialda) Market Size Market Share by Type (2020-2025)
Figure 45. Europe Mesalamine (Lialda) Market Size Market Share by Application (2020-2025)
Figure 46. Germany Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 47. France Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Mesalamine (Lialda) Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Mesalamine (Lialda) Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa Mesalamine (Lialda) Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Mesalamine (Lialda) Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 60. APAC Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 61. Europe Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 63. United States Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 64. Canada Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 65. Mexico Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 66. Brazil Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 67. China Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 68. Japan Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 69. Korea Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 71. India Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 72. Australia Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 73. Germany Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 74. France Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 75. UK Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 76. Italy Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 77. Russia Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 78. Egypt Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 79. South Africa Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 80. Israel Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 81. Turkey Mesalamine (Lialda) Market Size 2026-2031 ($ millions)
Figure 82. Global Mesalamine (Lialda) Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global Mesalamine (Lialda) Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries Mesalamine (Lialda) Market Size 2026-2031 ($ millions)